Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review.

ABSTRACT:

Background

Tuberculosis (TB) is still one of the most important causes of death worldwide. The lack of timely attention on TB diagnosis and treatment during the coronavirus disease 2019 (COVID-19) pandemic is a potential threat to health issues and may have severe consequences for patients and health systems. There is not much information on the management of TB during this period. Here, we reviewed the current literature to evaluate the rate of Mycobacterium tuberculosis and severe acute respiratory syndrome coronavirus 2 coinfections and interactions between these infectious agents.

Methods

Several databases, including Web of Science, Scopus, and MEDLINE (via PubMed), were searched for original articles addressing TB and COVID-19 diseases published from December 201

SUBMITTER: Bostanghadiri N 

PROVIDER: S-EPMC8851160 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature